Cite
HARVARD Citation
Cardone, C. et al. (2019). Exploratory findings from a prematurely closed international, multicentre, academic trial: RAVELLO, a phase III study of regorafenib versus placebo as maintenance therapy after first-line treatment in RAS wild-type metastatic colorectal cancer. ESMO open. 4 (4), p. . [Online].